11/7/2016

Desmopressin Injection

Products Affected - Description

- DDAVP injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 00075-2451-01
- DDAVP injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 00075-2451-53
- Desmopressin Acetate injection, Caraco, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 62756-0529-40
- Desmopressin Acetate injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 55566-5030-01
- Desmopressin Acetate injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 55566-5040-01
- Desmopressin Acetate injection, Pfizer, 4 mcg/mL, 1 mL ampule, 10 count, NDC 00409-2265-01
- Desmopressin Acetate injection, Teva, 4 mcg/mL, 1 mL vial, 10 count, NDC 00703-5051-03
- Desmopressin Acetate injection, Teva, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 00703-5054-01

Reason for the Shortage

- Teva and Hospira have desmopressin injection on shortage due to manufacturing delays.
- Ferring divested generic desmopressin to Amring Pharmaceuticals in January 2016.
- Caraco will not provide availability information at this time.

Available Products

- DDAVP injection, Ferring, 4 mcg/mL, 1 mL ampule, 10 count, NDC 55566-2200-00
- DDAVP injection, Ferring, 4 mcg/mL, 10 mL multiple dose vial, 1 count, NDC 55566-2300-00
- Desmopressin Acetate injection, Amring Pharmaceuticals, 4 mcg/mL, 1 mL ampule, 10 count, NDC 69918-0899-10
- Desmopressin Acetate injection, Amring Pharmaceuticals, 4 mcg/mL, 10 mL vial, 1 count, NDC 69918-0901-10

Estimated Resupply Dates

- Hospira has desmopressin 4 mcg/mL 1 mL ampules on back order and the company cannot estimate a release date.
- Teva has desmopressin 4 mcg/mL 1 mL and 10 mL vials on long-term back order and the company estimates a release date in fourth quarter of 2017.
- Amring and Ferring have had product available for several months and have been supplying the market.

Updated

Updated November 7, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 7, 2010 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.